new post
StocksRunner logo
mail
search
 
menu
 
Celldex Therapeutics
$29.88
-4.32%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

CLDX Stock Analysis & IQ Rating | Celldex Therapeutics

 
 

CLDX

 

Celldex Therapeutics

$29.88

 
-$1.35 | -4.32%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$31.99
 
 
MKT CAP
$1.99B
 
52W Low
$14.4
 
 
VOL
$683.77K
 
P/E Ratio
N/A
 
 
AVG VOL
$924.07K
 
RSI
60.15
 
 
TREND
Uptrend
 
 
 

CLDX Stock IQ

 
lock  Login to see Celldex Therapeutics (CLDX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

CLDX Target Price

 
 
 

Strengths

 
 

CLDX Rewards

 Upgraded on attractively valued

CLDX Rewards

 Earnings are forecast to grow

CLDX Rewards

 Trading below its fair value

 
 

CLDX Price Performance

 
 

$23.57   (+26.77%)

$27.09   (+10.30%)

$26.55   (+12.54%)

$19.98   (+49.55%)

 
 
1year
6month
3month
1month

CLDX Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

CLDX Earnings Sentiment Below analyst estimate

Rating

×

Rating

CLDX Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

CLDX Momentum Analysis Has been gaining momentum

Activity

×

Activity

Future

×

Future

CLDX Future Sentiment Earnings are forecast to grow
CLDX Future Sentiment Trading below its fair value
CLDX Analysts Opinion

CLDX Analysts opinion is negative and it remained unchanged from the past 3 months

CLDX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

71%
Consensus Rating
NA
Buy
Opinion
100%
Trend
Score
NA
Potential
Score
CLDX Street Sentiment

CLDX Street Sentiment is bullish and have negative views on the near-term outlook

CLDX Risk Level

CLDX has Fair risk level

Risk Indicators

Beta greater than 1.0
CLDX Risk Level
Fair
LOW
HIGH

CLDX Performance Sentiment

Sentiments overview associated with events and the stock performance

71%
Positive
5 out of 7
events present
14%
Negative
1 out of 7
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$22.94
Resistance Price
$31.23
Current Price Range
$31.23
$22.94
$31.23
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
1
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Oct 21, 2025

 

Initiate

 

Outperform

 

Mizuho

 
 
 
CLDX Latest Analysis +
 
 
FAQ About CLDX Stock Insights
 

What is CLDX current stock price?

What are CLDX stock strengths?

What is CLDX Risk Level?

What is CLDX market cap and volume?

What is CLDX current Stock IQ?

Should I buy CLDX stock right now?

Is CLDX a Strong Buy right now?

What does a 'Strong Buy' rating mean for CLDX?

What does a 'Strong Sell' rating mean for CLDX?

What factors influence CLDX's Stock IQ?

 
 
StocksRunner

Explore our CLDX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored CLDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CLDX Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

CLDX

 

Celldex Therapeutics

 
Set Alerts
 
 

Current Price

 

$29.88

 
-$1.35 | -4.32%
 
 
52W High
$31.99
 
 
MKT CAP
$1.99B
 
52W Low
$14.4
 
 
VOL
$683.77K
 
P/E Ratio
N/A
 
 
AVG VOL
$924.07K
 
RSI
60.15
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

CLDX Price Performance

 
 

$23.57   (+26.77%)

$27.09   (+10.30%)

$26.55   (+12.54%)

$19.98   (+49.55%)

 
 
1year
6month
3month
1month
 

CLDX Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

CLDX Earnings Sentiment Below analyst estimate

Rating

×

Rating

CLDX Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

CLDX Momentum Sentiment Has been gaining momentum

Activity

×

Activity

Future

×

Future

CLDX Future Sentiment Earnings are forecast to grow
CLDX Future Sentiment Trading below its fair value
CLDX Analysts Opinion

CLDX Analysts opinion is negative and it remained unchanged from the past 3 months

CLDX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

71%
Consensus Rating
NA
Buy
Opinion
100%
Trend
Score
NA
Potential
Score
CLDX Street Sentiment

CLDX Street Sentiment is bullish and have negative views on the near-term outlook

CLDX Risk Level

CLDX has Fair risk level

Risk Indicators

Beta greater than 1.0
CLDX Risk Level
Fair
LOW
HIGH
CLDX Performance Sentiment
Sentiments overview associated with events and the stock performance.
71%
Positive
5 out of 7
events present
14%
Negative
1 out of 7
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$22.94
Resistance Price
$31.23
Current Price Range
$31.23
$22.94
$31.23
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
1
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Oct 21, 2025
Initiate
Outperform
Mizuho
 
 
 
 

CLDX Stock IQ

 
 
 
lock  Login to unlock Celldex Therapeutics (CLDX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

CLDX Rewards

 Upgraded on attractively valued

CLDX Rewards

 Earnings are forecast to grow

CLDX Rewards

 Trading below its fair value

 
 
 

CLDX Latest Analysis

 
 
 

Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026. - Sustained off-treatment efficacy despite barzolvolimab clearance and normalization of tryptase suggesting disease modification in patients with CSU treated for full 52 weeks -- Greatly improved quality of life and reduced disease impac

 

Fri Feb 27, 2026

$30.09 | -1.80%
 
Activity

Celldex Therapeutics Stock Earns 88 RS Rating. Celldex Therapeutics sees its Relative Strength Rating enter the 80-plus level.The post Celldex Therapeutics Stock Earns 88 RS Rating appeared first on Investor'.s Business Daily.

 

Thu Feb 26, 2026

$30.64 | -0.58%
 
Technical

Celldex GAAP EPS of -$1.22 misses by $0.20 revenue of $0.12M misses by $1.34M.

 

Wed Feb 25, 2026

$30.82 | +24.07%
 
Earnings

Celldex surges after completing enrollments in late-stage trials for lead asset.

 

Wed Feb 25, 2026

$30.82 | +24.07%
 
Momentum

Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria. HAMPTON N.J. Feb. 25 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today the completion of enrollment in the Companys global Phase 3 program of barzolvolimab in chronic spontaneous urticaria (CSU) which consists of two Phase 3 trials—EMBARQ-CSU1 and EMBARQ-CSU2. 1939 patients were enrolled—the largest program conducted in antihistamine refractory CSU

 

Wed Feb 25, 2026

$30.82 | +24.07%
 
Activity
 
 
 
 
 
StocksRunner

Discover CLDX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of CLDX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CLDX Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CLDX Stock trends

CLDX Stock performance

CLDX Stock analysis

CLDX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

CLDX Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CLDX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CLDX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.